company background image
000710 logo

Berry GenomicsLtd SZSE:000710 Stock Report

Last Price

CN¥7.85

Market Cap

CN¥2.8b

7D

-1.6%

1Y

-27.4%

Updated

10 Jan, 2025

Data

Company Financials

Berry Genomics Co.,Ltd

SZSE:000710 Stock Report

Market Cap: CN¥2.8b

000710 Stock Overview

A genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. More details

000710 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Berry Genomics Co.,Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Berry GenomicsLtd
Historical stock prices
Current Share PriceCN¥7.85
52 Week HighCN¥13.16
52 Week LowCN¥5.40
Beta0.69
1 Month Change-28.18%
3 Month Change-3.09%
1 Year Change-27.45%
3 Year Change-63.18%
5 Year Change-81.09%
Change since IPO-88.43%

Recent News & Updates

Lacklustre Performance Is Driving Berry Genomics Co.,Ltd's (SZSE:000710) Low P/S

Dec 10
Lacklustre Performance Is Driving Berry Genomics Co.,Ltd's (SZSE:000710) Low P/S

Recent updates

Lacklustre Performance Is Driving Berry Genomics Co.,Ltd's (SZSE:000710) Low P/S

Dec 10
Lacklustre Performance Is Driving Berry Genomics Co.,Ltd's (SZSE:000710) Low P/S

Berry Genomics Co.,Ltd (SZSE:000710) Shares Fly 26% But Investors Aren't Buying For Growth

May 21
Berry Genomics Co.,Ltd (SZSE:000710) Shares Fly 26% But Investors Aren't Buying For Growth

Berry Genomics Co.,Ltd (SZSE:000710) Held Back By Insufficient Growth Even After Shares Climb 32%

Mar 08
Berry Genomics Co.,Ltd (SZSE:000710) Held Back By Insufficient Growth Even After Shares Climb 32%

Shareholder Returns

000710CN BiotechsCN Market
7D-1.6%-3.2%-1.1%
1Y-27.4%-23.1%4.2%

Return vs Industry: 000710 underperformed the CN Biotechs industry which returned -22.7% over the past year.

Return vs Market: 000710 underperformed the CN Market which returned 5.6% over the past year.

Price Volatility

Is 000710's price volatile compared to industry and market?
000710 volatility
000710 Average Weekly Movement7.5%
Biotechs Industry Average Movement6.3%
Market Average Movement7.2%
10% most volatile stocks in CN Market11.2%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 000710 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 000710's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19971,448Yang Gaowww.berrygenomics.com

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services.

Berry Genomics Co.,Ltd Fundamentals Summary

How do Berry GenomicsLtd's earnings and revenue compare to its market cap?
000710 fundamental statistics
Market capCN¥2.78b
Earnings (TTM)-CN¥281.85m
Revenue (TTM)CN¥1.11b

2.5x

P/S Ratio

-9.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000710 income statement (TTM)
RevenueCN¥1.11b
Cost of RevenueCN¥600.55m
Gross ProfitCN¥507.93m
Other ExpensesCN¥789.78m
Earnings-CN¥281.85m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 25, 2025

Earnings per share (EPS)-0.80
Gross Margin45.82%
Net Profit Margin-25.43%
Debt/Equity Ratio5.6%

How did 000710 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 08:29
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Berry Genomics Co.,Ltd is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yue GaoChangjiang Securities Co. LTD.
Hanqing ZhuGuosen Securities Co., Ltd.
Yinglan ShuHaitong International Research Limited